We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Ultrasound Better than Symptom Analysis in Diagnosing Ovarian Cancer

By MedImaging International staff writers
Posted on 31 Jul 2009
Investigators recently compared symptom analysis to ultrasound in predicting ovarian cancer. They selected 272 women participating in yearly transvaginal screening (TVS) from 31,748 women enrolled in a free screening project, comparing symptom results to ultrasound and surgical pathology findings.

The investigators, from the University of Kentucky Chandler Medical Center-Markey Cancer Center (Lexington, USA), discovered that TVS performed better than symptoms analysis for detecting malignancies (73.3% vs. 20% sensitivity). While symptoms analysis performed better for distinguishing benign tumors (91.3% versus 74.4% specificity), adding symptom analysis to TVS actually resulted in poorer identification of malignancy (sensitivity = 16.7%), even as it improved the ability to distinguish benign tumors (specificity = 97.9%).

The researchers, who published their findings online July 13, 2009 (print issue date: August 15, 2009) in the journal Cancer, reported that the data indicate that while symptoms do identify ovarian malignancies, they are not as accurate as TVS. They added that informative symptoms could be expected to be absent in 80% of ovarian malignancies.

Related Links:
University of Kentucky Chandler Medical Center-Markey Cancer Center

Ultrasonic Pocket Doppler
SD1
Digital Radiographic System
OMNERA 300M
40/80-Slice CT System
uCT 528
Breast Localization System
MAMMOREP LOOP

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.